2230
/ 1
Min Read
Glenmark Pharmaceuticals has launched its hair loss treatment product 'Nourkrin' in the Russian market. It caters to both male and female patients.
Under a licensing agreement with Denmark's Pharma Medico ApS, the product will be exclusively marketed in Russia by Glenmark Impex LLC.
Nourkrin Woman has already been introduced in India early this year.
Csaba Kantor, Senior Vice President & Head - Asia, Russia & CIS, Glenmark Pharmaceuticals, said, "It is a much-awaited product, as the problem of hair loss affects quite a significant proportion of the population. Glenmark has a strong portfolio of dermatology products in Russia... Nourkrin will be a great addition to this portfolio."
Nourkrin Woman and Nourkrin Man are available as tablets. They will be accessible through retail pharmacy chains as well as online pharmacies.
